Poly I:C Pre-Treatment Induced the Anti-Viral Interferon Response in Airway Epithelial Cells
Viruses · 2023
DOI: 10.3390/v15122328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Hannah Mitländer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pneumology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91054 Erlangen, Germany. Hauptthemen laut MEDLINE: Asthma, Picornaviridae Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlan-gen-Nuremberg (MD-Thesis Scholarship Programme "A82…, SFB, Collaborative Research Centre (CRC) 1181 (Erlangen).
Abstract (Originalsprache)
Type I and III interferons are among the most important antiviral mediators. Increased susceptibility to infections has been described as being associated with impaired interferon response in asthmatic patients. In this work, we focused on the modulation of interferon dysfunction after the rhinovirus infection of airway epithelial cells. Therefore, we tested polyinosinic:polycytidylic acid (poly I:C), a TLR3 agonist, as a possible preventive pre-treatment to improve this anti-viral response. In our human study on asthma, we found a deficiency in interferon levels in the nasal epithelial cells (NEC) from asthmatics at homeostatic level and after RV infection, which might contribute to frequent airway infection seen in asthmatic patients compared to healthy controls. Finally, pre-treatment with the immunomodulatory substance poly I:C before RV infection restored IFN responses in airway epithelial cells. Altogether, we consider poly I:C pre-treatment as a promising strategy for the induction of interferon response prior to viral infections. These results might help to improve current therapeutic strategies for allergic asthma exacerbations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pneumology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
- Department of Medicine 1, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
ORCID-Profile: Susanne Krammer, Susetta Finotto
Förderung
- Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlan-gen-Nuremberg (MD-Thesis Scholarship Programme "A82…
- SFB
- Collaborative Research Centre (CRC) 1181 (Erlangen)
- European Grant Horizon SynAir-G
- Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg
- Department of Molecular Pneumology
- Collaborative Research Centre
- German Research Foundation (DFG) at the University hospital in Erlangen, Germany
Zitieren
APA
Mitländer, H., Yang, Z., Krammer, S., Grund, J. C., Zirlik, S., & Finotto, S. (2023). Poly I:C Pre-Treatment Induced the Anti-Viral Interferon Response in Airway Epithelial Cells. Viruses. https://doi.org/10.3390/v15122328
Vancouver
Mitländer H, Yang Z, Krammer S, Grund JC, Zirlik S, Finotto S. Poly I:C Pre-Treatment Induced the Anti-Viral Interferon Response in Airway Epithelial Cells. Viruses. 2023. doi:10.3390/v15122328
BibTeX
@article{Mitlnder2023,
author = {Mitländer, Hannah and Yang, Zuqin and Krammer, Susanne and Grund, Janina C and Zirlik, Sabine and Finotto, Susetta},
title = {Poly I:C Pre-Treatment Induced the Anti-Viral Interferon Response in Airway Epithelial Cells},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15122328}
}
EUVIMED